Helius Medical Technologies, Inc. announces impairment charges for the three months ended September 30 2023. For the quarter, the company reported Goodwill and fixed asset impairment of $159,000 against $757,000 a year ago.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.687 USD | +3.52% | -30.28% | -79.01% |
10:11pm | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000 | MT |
10:09pm | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000, vs. Street Est of $0.1M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.01% | 4.38M | |
+11.29% | 226B | |
+8.76% | 188B | |
+12.90% | 137B | |
+25.95% | 108B | |
+0.34% | 63.19B | |
+11.08% | 52.26B | |
+5.62% | 51B | |
+6.28% | 43.89B | |
+4.80% | 38.07B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Announces Impairment Charges for the Three Months Ended September 30 2023